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Introduction
Systematic review is a method for systematically appraising, 
synthesising, and evaluating the available research in 
response to a particular question (Chalmers 1993). Systematic 
reviews have become increasingly important means of 
building an evidence base that informs clinical practice 
and identifying areas of healthcare that require further 
research. Meta-analysis is often performed in conjunction 
with systematic review and provides a statistical method for 
pooling the results of studies. The increased sample size 
and inclusion of multiple studies in a meta-analysis result 
in a more powerful and rigorous estimate of the effect of 
intervention than can be obtained from individual studies 
(Egger et al 1997).
There is evidence that in clinical trials where allocation is 
not concealed and assessors, therapists, and participants 
are not blinded, a larger effect of intervention is reported 
than in higher quality trials with adequate blinding 
procedures (Egger et al 2003, Schulz et al 1995). Therefore, 
an important step in conducting a systematic review is to 
assess the methodological quality of each included trial. 
Furthermore, the use of different scales to assess the quality 
of clinical trials in systematic reviews has been shown to 
lead to different conclusions (Colle et al 2002). Some 
reviewers rate the methodological quality of clinical trials 
in order to conduct sensitivity analysis or meta-regression, 
to exclude low quality trials or to weight them less heavily 
in a meta-analysis. In addition, reporting methodological 
quality provides clinicians with information about whether 
the results of clinical trials should influence their clinical 
practice. A valid way of assessing the methodological 
quality of clinical trials is therefore essential.
Although there are many scales which assess the quality 
of clinical trials, the PEDro scale is commonly employed 
(Maher et al 2003). The Pedro scale scores 10 items: random 
allocation, concealed allocation, similarity at baseline, 
subject blinding, therapist blinding, assessor blinding, > 
85% follow up for at least one key outcome, intention-to-
treat analysis, between-group statistical comparison for at 
least one key outcome, and point and variability measures 
for at least one key outcome. Items are scored as either 
present (1) or absent (0) and a score out of 10 is obtained 
by summation. Maher et al (2003) reported an inter-rater 
reliability generalised kappa statistic of between 0.40 and 
0.75 for the PEDro scale.
No scales for assessing the methodological quality of 
clinical trials have been subjected to Rasch analysis. Rasch 
analysis offers a sophisticated method for assessing whether 
an instrument measures only one construct, in this case, the 
methodological quality of clinical trials (ie, whether it is 
unidimensional). If all PEDro scale items are measuring 
the same construct, the summation of individual items to 
obtain a total score of methodological quality of the clinical 
trial is valid. Alternatively, Rasch analysis may identify 
redundant items, ie, items that are similar to each other 
or items that measure a different construct. For example, 
if an item is not clearly understood within the research 
community and is subsequently poorly reported, this item 
is influenced by factors other than methodological quality. 
In this case, the summation of individual items to obtain 
a total score of methodological quality of the clinical trial 
would be invalid.
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Research
Rasch analysis ranks items in a hierarchy of difficulty. 
Difficulty, a commonly used concept in relation to Rasch 
modeling, in this case refers to whether an item was adhered 
to or not. Ranking items from the most to least adhered to 
may assist triallists to identify items that require particular 
attention when planning and reporting a clinical trial.
The CONSORT statement was originally published in 
1996 (Begg et al 1996) and provides recommendations for 
the reporting of randomised trials. These guidelines have 
slowly been endorsed by journals over time. Therefore, year 
of publication is a factor that could influence adherence to 
individual items as a result of improved reporting of specific 
trial methods over time.
An advantage of Rasch analysis is that it allows interval 
data to be obtained from ordinal level scores. Interval level 
measurement provides greater accuracy when comparing 
scores between clinical trials. For example, the difference 
in methodological quality between clinical trials that 
score 5 and 6 compared to 6 and 7 is equidistant on an 
interval level scale. This is not the case for ordinal level 
measurement where the scores represent only directional 
differences and not the magnitude of the difference in the 
methodological quality between the clinical trials. Interval 
level measurement therefore provides more meaningful 
information for clinicians and researchers.
The aim of this study was to ascertain whether the PEDro 
scale is a valid measure of the methodological quality of 
clinical trials. Therefore, the specific research questions 
were:
Does the PEDro scale measure only one construct ie, 1. 
the methodological quality of clinical trials?
What is the hierarchy of items of the PEDro scale 2. 
from least to most adhered to?
Is there any effect of year of publication of trials on 3. 
item adherence?
Are PEDro scale ordinal scores equivalent to interval 4. 
data?
Method
Design
Clinical trials (up to July 2006) were randomly selected 
from the PEDro database using the random generation 
function in Microsoft Excel. Of 7663 available trials, 200 
trials were extracted and randomised into two independent 
samples of 100 using the random generation function in 
Microsoft Excel. Total PEDro scale scores and individual 
item scores were extracted for each clinical trial. Year of 
publication and area of physiotherapy intervention were 
also extracted for each study.
Data analysis
Linacre (1994) proposed that for most purposes a sample 
size of 100 (64–144) will provide 95% confidence of 
item calibration +/–0.5 logits (log-odds units). Therefore 
two independent samples of 100 were included for Rasch 
analysis in this study.
The Rasch model has two assumptions. The first is that 
items measure a single underlying construct, thereby 
forming a ‘unidimensional’ scale. For the PEDro scale, 
fit to the Rasch model would indicate that the PEDro data 
is measuring the construct of ‘trial quality.’ The second 
assumption is that items have local independence. This 
requires that responses to one item are not dependent on 
the responses to another item or that ‘after controlling for 
the underlying trait, item responses are independent’ (Smith 
2005). Residuals from Rasch analysis were examined to 
investigate these assumptions. A finding of no association 
between residuals for individual items has been argued as 
evidence of local item independence (Smith 2002). High 
positive correlation between residuals provides evidence 
of local item dependence and high negative correlation is 
thought to indicate multidimensionality.
Unidimensionality was formally tested by examining the 
principal component loadings of the residuals (Smith 2002, 
Tennant and Pallant 2006). Items were identified that loaded 
either positively or negatively on the first residual component 
after Rasch analysis and two item subsets were created. 
Trial location estimates were obtained using the differing 
item subsets as these subsets are expected to provide the 
most disparate item locations. A series of independent 
t-tests were conducted to compare study location estimates 
obtained using the differing item subsets. The percentage of 
t-tests outside the acceptable range of 2 standard deviations 
was then calculated with an accompanying binomial 
proportions 95% confidence interval (SISA 2007). Tennant 
and Pallant (2006) recommend that a result of less than 5% 
(or the binomial 95% CI crossing 5%) is the most robust 
method for confirming scale unidimensionality.
Table 1. Characteristics of clinical trials.
Characteristic Sample 1 
(n = 100)
Sample 2 
(n = 100)
Year of publication, n = %
 1960s
 1970s
 1980s
 1990s
 2000s
1
6
17
36
40
0
3
12
33
52
Area of physiotherapy 
intervention, n = %
 Musculoskeletal
 Cardiothoracics
 Neurology
 Paediatrics
 Medical
 Other
 
46
11
12
2
15
14
 
48
13
9
7
11
12
PEDro score, mean (SD) 4.8 (1.6) 5.2 (1.5)
Item adherence, n = %
 Eligibility
 Random allocation
 Concealed allocation
 Similarity at baseline
 Subject blinding
 Therapist blinding
 Assessor blinding
 > 85% follow-up
 Intention-to-treat analysis
  Between-group statistical 
comparison
  Point and variability 
measures
74
93
22
64
13
2
40
54
19
88
 
80
76
96
29
76
5
3
34
67
25
93
 
92
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The data were also examined for extreme studies that may 
occur if all items were successfully adhered to or all items 
were unsuccessfully adhered to. Responses for these studies 
would not fit the Rasch model because they would have a 
theoretical logit location of + ∞ or – ∞ respectively.
Differential item functioning occurs when items operate 
differently for the same total score based on another 
variable. The data were therefore examined for differential 
item functioning by year of publication in the following 
categories: 1969–1989, 1990–1999 and 2000–2006 and 
were considered significant if the χ2 p value was lower than 
the Bonferroni-adjusted p value.
Rasch analysis was performed in this study using 
RUMM2020 softwarea and SPSS version 12.0. The 
unrestricted Rasch partial credit model was employed to 
investigate overall model fit, item misfit, differential item 
functioning and item thresholds. Studies were divided into 
three class intervals (ie, three groups of studies of different 
levels of ‘quality,’ low, medium and high). A significant 
likelihood ratio test for both samples (p = 0.00) justified the 
use of the unrestricted Rasch partial credit model.
Results
Characteristics of clinical trials
The characteristics of the clinical trials included in each 
sample are presented in Table 1. In Sample 1, the mean total 
PEDro score was 4.8 (SD 1.6) and the year of publication 
ranged from 1966 to 2006. In Sample 2, the mean total 
PEDro score was 5.2 (SD 1.5) and the year of publication 
ranged from 1972 to 2006.
Construct validity
In Sample 1, PEDro data fitted the Rasch model (item-trait 
χ2 = 23.97, p = 0.24) and the percentage of t-tests outside the 
acceptable range was 3% (95% CI –1 to 7). Items ranged from 
approximately –3 logits for the most adhered to item random 
allocation, to the least adhered to item at approximately +3 
logits therapist blinding. There were no trials that were 
extreme and none of the PEDro items showed misfit to the 
Rasch model. There was no local item dependence. Three 
PEDro scale items had positive correlations with the first 
residual component (the first factor after conducting Rasch 
analysis) of > 0.30: subject blinding (r = 0.70), therapist 
blinding (r = 0.64), and assessor blinding (r = 0.46) while 
three items had negative correlations of > 0.30: intention-
to-treat analysis (r =-0.37), between-group statistical 
comparison (r = –0.53), and similarity at baseline (r = 
–0.53). In Sample 2, PEDro data also fitted the Rasch model 
(item-trait χ2 = 20.85, p = 0.41) and the percentage of t-tests 
outside the acceptable range was 4% (95% CI 0 to 8). There 
was some local item dependence with a positive correlation 
of the residuals between the items subject blinding and 
therapist blinding (r = 0.64).
Hierarchy of items
The order of PEDro scale items from least to most adhered 
to was identical for Sample 1 and 2 (Table 1, Box 1). This 
is also shown in Figure 1 where items from both samples 
are placed on the same logit scale (logit units) where the 
most adhered to items are located on the left of the graph 
in negative logit locations and the least adhered to items 
are located on the right side of the graph in positive logit 
locations.
Year of publication
In Sample 1, there was no differential item functioning by 
year identified. In Sample 2, although significant differential 
item functioning was identified for the subject blinding and 
therapist blinding items, these were likely to be statistical 
artifacts due to the small number of trials in the third class 
interval for the 1966–1989 category.
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Figure 1. Mean (95% CI) logit location of PEDro scale items for Sample 1 (black line) and Sample 2 (blue line). The most 
adhered to items are on the left and the least adhered to are on the right. The 95% CI between samples overlap for all items 
except subject blinding.
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Ordinal vs interval data
Transformed PEDro interval scores were highly correlated 
with original PEDro ordinal scores for Sample 1 (r = 0.99) 
and 2 (r = 0.99) (Figure 2).
Discussion
The results of Rasch analysis in this study indicate that 
the PEDro scale measures only one construct – the 
methodological quality of clinical trials. Since there 
was no redundancy of PEDro scale items, it is valid to 
combine PEDro item scores to obtain a total PEDro score 
as an indicator of methodological quality. Furthermore, the 
finding that there were no redundant items amongst the 10 
PEDro scale items, suggests that the PEDro scale assesses 
a reasonable breadth of methodological quality. Clinicians 
and researchers can therefore confidently use the PEDro 
scale to assess the methodological quality of clinical trials 
of physiotherapy interventions.
The hierarchy of item adherence (least to most adhered 
to) of the PEDro scale was identical across the samples. 
Random allocation, between-group statistical comparison, 
point and variability measures and similarity at baseline 
were the most adhered to items in both samples. However, 
since the PEDro database is a database of randomised and 
quasi-randomised trials, it would be expected that random 
allocation would be one of the most adhered to items. If the 
clinical trials had been selected from the broader literature, 
it is unlikely that this item would be identified as the most 
adhered to item. Therapist and subject blinding were the 
least adhered to items in both samples. Unlike in drug trials, 
both therapist blinding and subject blinding are difficult to 
achieve in complex intervention trials. In most clinical trials 
of physiotherapy intervention, it is not possible to blind 
the therapist providing the intervention. It is therefore not 
surprising that therapist blinding was identified as the least 
adhered to in both samples. Similarly, it is also difficult to 
blind participants to the physiotherapy intervention that 
they are receiving except in trials of electrotherapeutic 
interventions. Concealed allocation was the third least 
adhered to item. This may reflect some confusion that exists 
regarding the concept or definition of concealed allocation. 
Furthermore, whether items were adhered to or not is likely 
to be dependent not only on whether items were implemented 
in practice during the trial but also the researchers’ abilities 
to write trial reports.
Although the CONSORT statement was originally published 
in 1996 (Begg et al 1996), no differential item functioning 
by year was identified in this study; this indicates that the 
relative adherence to different items has not changed over 
time, suggesting that it has not been influenced by the 
introduction of the statement.
There was a high correlation between the original PEDro 
ordinal scores and transformed interval PEDro scores 
suggesting that PEDro ordinal scores can confidently be 
used as an accurate estimate of interval level measurement 
without requiring conversion to interval scores. Since a 
requirement for parametric analysis is that the data are 
interval or ratio level measurements, PEDro scores can 
confidently be subjected to parametric statistical analysis.
In conclusion, the PEDro scale is a valid measure of 
methodological quality of clinical trials. Its items were 
ranked hierarchically from the least to the most adhered to 
item without redundancy. Since there was a high correlation 
between original PEDro ordinal scores and transformed 
PEDro interval scores, PEDro data can be treated as 
interval level measurement. These findings support the use 
of the PEDro scale for assessing the methodological quality 
of clinical trials. n
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Figure 2. Relationship between original PEDro ordinal 
scores and transformed PEDro interval scores for Sample 1 
(black line) and Sample 2 (blue line).
Box 1. Hierarchy of PEDro items across Sample 1 and 2
Least 
adhered to
Therapist blinding
Subject blinding
Intention-to-treat analysis
Concealed allocation
Assessor blinding
> 85% follow up
Similarity at baseline
Point and variability measures
Between-group statistical comparison
Most 
adhered to
Random allocation
Australian Journal of Physiotherapy 2009  Vol. 55  –   © Australian Physiotherapy Association 2009 133
de Morton: Validity of the PEDro scale
References
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I et 
al (1996) Improving the quality of reporting of randomized 
controlled trials. The CONSORT statement. JAMA 276: 637–
639.
Chalmers A (1993) The Cochrane collaboration: preparing, 
maintaining, and disseminating systematic reviews of the 
effects of health care. Annals of the New York Academy of 
Sciences 703: 156–163.
Colle F, Rannou F, Revel M, Fermanian J, Poiraudeau S (2002) 
Impact of quality scales on levels of evidence inferred from 
a systematic review of exercise therapy and low back pain. 
Archives of Physical Medicine and Rehabilitation 83: 1745–
1752.
Egger M, Bartlett C, Hoelstein F, Sterne J (2003) How important 
are comprehensive literature searches and the assessment 
of trial quality in systematic reviews? Health Technology 
Assessment 7: 1–76.
Egger M, Smith G, Phillips A (1997) Meta-analysis: principles 
and procedures. BMJ 315: 1533–1537.
Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins 
M (2003) Reliability of the PEDro scale for rating quality of 
randomized controlled trials. Physical Therapy 83: 713–721.
Schulz K, Chalmers I, Hayes R, Altman DG (1995) Empirical 
evidence of bias: dimensions of methodological quality 
associated with estimates of treatment effects in controlled 
trials. JAMA 273: 408–412.
Simple Interactive Statistical Analysis (SISA) (2007) Binomial 
calculator. Accessed July 8th 2008 from http://home.clara.
net/sisa/binomial.htm,
Smith E (2002) Detecting and evaluating the impact of 
multidimensionality using item fit statistics and principal 
components analysis of residuals. Journal of Applied 
Measurement 3: 205–231.
Smith E (2005) Effect of item redundancy on Rasch item and 
person estimates. Journal of Applied Measurement 6: 147–
163.
Tennant A, Pallant J (2006) Unidimensionality matters! (A 
tale of two Smiths?). Rasch Measurement Transactions 20: 
1048–1051.
Wright B, Stone M (1979) Best-test Design. Chicago: Messa 
Press.
Websites
http://www.pedro.org.au/
http://home.clara.net/sisa/binomial.htm
http://www.rummlab.com/
